AMGN vs NCL · P/E 24, rev $10.05B vs rev $5.0M
Amgen Inc (AMGN) versus Northann Corp. (NCL) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Northann Corp. (NCL) is a furnishings, fixtures & appliances company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported NCL revenue for 2026-03-31 was $5.0M. Net income was -$2.9M. Revenue was up 39.9% from 2025-09-30 to 2026-03-31. NCL currently screens at market cap $9.1M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. NCL currently screens at market cap $9.1M.
Not investment advice. Open the AMGN and NCL stock pages for the full models.
Not investment advice.